ILLUMINA
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
5200 Illumina Way, San Diego, California...Phone Number
(858) 202-4500Website
www.illumina.comRevenue
$4.4 BillionStock Symbol
ILMNIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
20
14
1
2
2
2
About ILLUMINA
Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories,Read more
ILLUMINA Org Chart
WF
Vice President of Pharmaceutical and Biotech ...
RS
Scientist, Infectious Disease and Vice Presid...
IG
Vice President, AI Precision Medicine
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ILLUMINA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if ILLUMINA has recently received funding, and reach out quickly before it becomes old news!
ILLUMINA, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on ILLUMINA recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at ILLUMINA
Website visits: Recent activity has been detected on your website
Check out if ILLUMINA is spiking on competitors!
Click to see if ILLUMINA had a recent Job posting/layoffs
Product Launch: Get notified when ILLUMINA launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once ILLUMINA has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to ILLUMINA
Compare insights from companies similar to ILLUMINA, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ILLUMINA is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ILLUMINA is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ILLUMINA.
ILLUMINA financials insights
Gather financial insights about ILLUMINA, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2000
Stock Offering
$96M
2023
Debt
$750M
ILLUMINA Tech Stack
A closer look at the technologies used by ILLUMINA
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
ILLUMINA News & Media
Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research
Automating library prep reduces hands-on time for customers using Pillar Biosciences oncoReveal® targeted oncology research panels SAN DIEGO, May 28, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) and SPT Labtech today introduced the fireflyGO automation platform, a new benchtop...Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research
An advanced research workflow for fast, flexible detection of molecular residual disease during and following treatment Solution is the first in a new WGS oncology portfolio, building on Illumina's history of leadership as foundation for MRD market SAN DIEGO, May 28, 2026 /PRNewswire/ --...David P. King elected to Illumina's Board of Directors
Former Labcorp Chairman and CEO brings deep healthcare, diagnostics, and clinical expertise to Illumina's Board SAN DIEGO, May 21, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today confirmed the election of David P. King to its Board of Directors, effective immediately following...Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact
SAN DIEGO, May 19, 2026 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) today published its annual Corporate Responsibility (CR) Report. The report highlights the company's continued progress in expanding equitable access to genomics while delivering measurable impact for patients,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ILLUMINA
Sign Up For FreeTo access detailed company insights
Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library prepar... Read More
